SecSonar.com

ResMed Inc. (RMD)

ResMed Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

ResMed Inc. (RMD) is a Medical - Devices company based in US with a market capitalization of $28.3B. Revenue grew 9.8% year-over-year and the company generated $1.7B in free cash flow. This page tracks RMD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 9.98K employees · IPO Jun 2, 1995

Valuation

Valuation & price

$201.88 · as of May 17, 2026 · -31.3% vs 52w high

21.2

P/E ratio

Latest-FY diluted EPS

4.74

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$291$239$186Jul 25Dec 25Jul 26Jul 7, 25$256.41Jul 9, 25$255.98Jul 11, 25$254.40Jul 15, 25$252.01Jul 17, 25$256.42Jul 21, 25$261.07Jul 23, 25$273.37Jul 25, 25$275.16Jul 29, 25$277.70Jul 31, 25$271.94Aug 4, 25$291.44Aug 6, 25$280.46Aug 11, 25$284.32Aug 13, 25$288.28Aug 15, 25$284.89Aug 19, 25$286.04Aug 21, 25$288.34Aug 25, 25$285.80Aug 27, 25$281.96Aug 29, 25$274.51Sep 3, 25$269.21Sep 5, 25$277.05Sep 9, 25$279.19Sep 11, 25$274.61Sep 16, 25$272.60Sep 18, 25$273.29Sep 22, 25$274.41Sep 24, 25$274.19Sep 26, 25$270.27Sep 30, 25$273.73Oct 2, 25$276.64Oct 6, 25$281.38Oct 8, 25$282.35Oct 10, 25$272.00Oct 14, 25$270.07Oct 16, 25$270.00Oct 21, 25$268.22Oct 23, 25$265.26Oct 27, 25$259.21Oct 29, 25$253.62Oct 31, 25$246.88Nov 4, 25$246.40Nov 6, 25$249.65Nov 10, 25$250.10Nov 12, 25$252.86Nov 14, 25$244.46Nov 18, 25$246.22Nov 20, 25$243.92Nov 25, 25$255.80Nov 28, 25$255.83Dec 2, 25$250.85Dec 4, 25$251.51Dec 8, 25$250.04Dec 10, 25$251.50Dec 12, 25$252.27Dec 16, 25$247.34Dec 18, 25$242.55Dec 22, 25$246.67Dec 24, 25$244.44Dec 29, 25$242.85Jan 2, 26$244.81Jan 6, 26$249.19Jan 8, 26$250.92Jan 12, 26$257.84Jan 14, 26$259.51Jan 16, 26$257.58Jan 21, 26$259.28Jan 23, 26$252.38Jan 27, 26$255.50Jan 29, 26$257.61Feb 2, 26$254.74Feb 4, 26$263.03Feb 9, 26$275.96Feb 11, 26$259.62Feb 13, 26$252.55Feb 18, 26$258.91Feb 20, 26$259.12Feb 24, 26$251.63Feb 26, 26$257.06Mar 2, 26$257.39Mar 4, 26$259.05Mar 6, 26$252.87Mar 10, 26$247.11Mar 12, 26$232.41Mar 17, 26$233.50Mar 19, 26$227.41Mar 23, 26$227.97Mar 25, 26$226.31Mar 27, 26$220.47Mar 31, 26$224.48Apr 2, 26$224.09Apr 7, 26$226.05Apr 9, 26$227.98Apr 13, 26$230.26Apr 15, 26$228.80Apr 17, 26$228.12Apr 22, 26$222.04Apr 24, 26$219.85Apr 28, 26$217.14Apr 30, 26$213.81May 4, 26$209.43May 6, 26$209.64May 8, 26$206.76May 12, 26$203.79May 14, 26$202.46May 18, 26$204.15May 20, 26$209.86May 22, 26$208.05May 28, 26$203.42Jun 1, 26$186.44Jun 3, 26$186.46Jun 5, 26$196.04Jun 9, 26$196.94Jun 11, 26$192.39Jun 15, 26$192.74Jun 17, 26$186.29Jun 22, 26$188.45Jun 24, 26$196.50Jun 26, 26$200.29Jul 2, 26$209.63
$182.8252-week range$293.73
Loading valuation history…

Fundamentals

Key fundamentals

$28.3B

Market cap

9.8%

Revenue growth (YoY)

59.4%

Gross margin

$1.7B

Free cash flow (USD)

-$357.6M

Net debt

Net cash position

-0.2%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.8BFY 2017$2.1BFY 2018$2.3BFY 2019$2.6BFY 2020$3.0BFY 2021$3.2BFY 2022$3.6BFY 2023$4.2BFY 2024$4.7BFY 2025$5.1B
$1.8B$5.1B

Free cash flow by year

2016 → 2025

FY 2016$480.1MFY 2017$342.6MFY 2018$433.6MFY 2019$381.7MFY 2020$696.3MFY 2021$619.9MFY 2022$195.1MFY 2023$559.3MFY 2024$1.3BFY 2025$1.7B
$480.1M$1.7B

Gross margin by year

2021 → 2025

FY 202157.5%FY 202256.6%FY 202355.8%FY 202456.7%FY 202559.4%
57.5%59.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

3

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $968K · 10b5-1 PlanFarrell Michael J. · Director, Chairman and CEO · $968.1KJun 9, 2026Filing
  • Insider sellInsider Sell $1.0M · 10b5-1 PlanFarrell Michael J. · Director, Chairman and CEO · $1MMay 11, 2026Filing
  • Quarterly report10-Q FiledMay 1, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing
  • 8-K eventCFO Retirement and AppointmentApr 30, 2026Filing
  • Insider sellInsider Sell $1.1M · 10b5-1 PlanFarrell Michael J. · Director, Chairman and CEO · $1.1MApr 9, 2026Filing
  • Insider sellInsider Sell $224K · 10b5-1 PlanSandercock Brett · Chief Financial Officer · $224.3KApr 3, 2026Filing
  • Insider sellInsider Sell $450K · 10b5-1 PlanFARRELL PETER C · Director · $450KApr 2, 2026Filing

Questions

Frequently asked questions

What is ResMed Inc.'s market cap?

ResMed Inc. (RMD) has a market capitalization of $28.3B.

What is RMD's P/E ratio?

RMD trades at a price-to-earnings ratio of 21.2, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is RMD's price-to-book (P/B) ratio?

RMD trades at 4.74 times book value per share.

Are insiders buying RMD stock?

SEC Form 4 filings show no open-market insider buys at ResMed Inc. in the last 90 days (3 sells).

Same arena

Related companies in Medical - Devices

DXCM

DexCom, Inc.

$28.4B

PHG

Koninklijke Philips N.V.

$25.3B

STE

STERIS plc

$20.9B

ZBH

Zimmer Biomet Holdings, Inc.

$16B

SNN

Smith & Nephew plc

$12.7B

ALGN

Align Technology, Inc.

$12.6B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.